LGALS1 and neoplasm: On another note, inhibition of Gal-1 by the calix[4]arene derivative compound OTX008, showing a half-maximal inhibitory concentration (IC50) from 1 to 190 μM against Gal-1, has been experimented for tumor targeting [12,13,14].